CompletedNot Applicable

Spectral Diagnosis of Cutaneous Malignancy

United States350 participantsStarted 2007-04

Plain-language summary

The goal of this clinical research study is to evaluate the use of an imaging technology called spectral diagnosis. Researchers want to find out if a special spectral-diagnosis probe can be used to detect skin cancers.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Male or Female and over 18 years of age.
✓. Patients undergoing an examination of their skin
✓. Patients with a lesion(s) in one of the five categories: basal cell carcinoma, squamous cell carcinoma, pre-cancer lesions, pigmented lesions, and benign lesions
✓. Patients whose lesion also warrants a biopsy.
✓. Signed informed consent document.

Exclusion criteria

✕. Patients with absence of skin lesion(s) in one of the five categories.
✕. Patients whose identified lesion did not need a biopsy.
✕. Patients who did not sign the informed consent and agree to participate.

What they're measuring

Spectroscopic features of skin lesions in vivo

Timeframe: Preparing lesion, imaging it, and collecting the light signals should take about 10-15 minutes per lesion.

Trial details

NCT IDNCT00476905

SponsorM.D. Anderson Cancer Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2018-11-20

View on ClinicalTrials.gov More Skin Cancer trials